Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages
Titel:
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages
Auteur:
Gomez-Roca, C.A. Italiano, A. Le Tourneau, C. Cassier, P.A. Toulmonde, M. D’Angelo, S.P. Campone, M. Weber, K.L. Loirat, D. Cannarile, M.A. Jegg, A.-M. Ries, C. Christen, R. Meneses-Lorente, G. Jacob, W. Klaman, I. Ooi, C.-H. Watson, C. Wonde, K. Reis, B. Michielin, F. Rüttinger, D. Delord, J.-P. Blay, J.-Y.